Electroconvulsive therapy (ECT)

What this is

The single most effective treatment for severe and treatment-resistant depression — and one of the most stigmatized. Modern ECT (general anesthesia + muscle relaxants + ultrabrief-pulse + right-unilateral electrode placement) bears little resemblance to the un-anesthetized procedure depicted in "One Flew Over the Cuckoo's Nest" (1975). ELEKT-D (Anand 2023 NEJM n=403) showed IV ketamine NONINFERIOR to ECT in non-psychotic TRD with fewer cognitive side effects — shifted first-line TRD practice toward ketamine when available; ECT remains preferred for psychotic depression; severe suicidality; catatonia; mania; pregnancy; and medically complex elderly. 2024 ELEKT-D inpatient subgroup analysis: severe/inpatient cases get more early benefit from ECT; outpatient/moderate cases match on ketamine. 2025 ELEKT-D cognitive secondary analysis (Lancet Psych) confirmed ECT had significantly worse scores across all cognitive tasks at end of treatment; gap narrowed at 6 months. 2024 autobiographical-memory MA (n=432 + 173 controls) found ECT patients had larger autobiographical memory loss immediately post-treatment vs controls. 2024 international patient survey (Int J Mental Health) found 71% of recipients reported anterograde amnesia and 80% retrograde amnesia lasting >3 years — though objective neuropsych testing typically shows less impairment than patient-reported. The patient-experience gap is the main reason ECT remains controversial despite efficacy. Listed in this database because biohacker readers need a calibrated reference point: ECT is the high-water mark of efficacy in mental health against which newer interventions (ketamine; zuranolone; KarXT; psilocybin; TMS) are benchmarked. Not a biohacking intervention — included for completeness of the mental health landscape.

Mechanism

Brief electrical stimulus (0.5-8 sec) delivered under general anesthesia and neuromuscular blockade induces a controlled generalized tonic-clonic seizure (~30-90 sec); proposed antidepressant mechanisms include massive monoamine release; HPA-axis normalization; BDNF/neuroplasticity upregulation; anti-inflammatory effects; hippocampal neurogenesis; and seizure-induced default-mode-network reconfiguration; modern technique uses brief or ultrabrief pulse plus right-unilateral electrode placement to minimize cognitive side effects

Dose & route

Acute course typically 2-3 sessions/week x 6-12 sessions; maintenance 1-4 sessions/month for relapse prevention; ultrabrief-pulse right-unilateral minimizes cognitive side effects vs. bitemporal/brief-pulse

Citations

• https://www.nejm.org/doi/full/10.1056/NEJMoa2302399
• https://pubmed.ncbi.nlm.nih.gov/40900112/
• https://www.nature.com/articles/s41380-025-03327-z
• https://pubmed.ncbi.nlm.nih.gov/40357797/
• https://www.tandfonline.com/doi/full/10.1080/00207411.2025.2576946
• https://pubmed.ncbi.nlm.nih.gov/37012942/

Links go to the source. If a link is dead or you want something re-checked, let me know.